Table 2.
Variations | P | RR | CI (95%) |
---|---|---|---|
Sex |
0.671 |
1.106 |
0.694-1.765 |
Male versus female |
|
|
|
Age |
0.179 |
1.148 |
0.938-1.405 |
<50 |
|
|
|
50-59 |
|
|
|
60-69 |
|
|
|
> = 70 |
|
|
|
Tumor location |
0.545 |
0.864 |
0.538-1.387 |
Cardia vs. Non-cardia |
|
|
|
Differentiation |
0.301 |
0.751 |
0.437-1.292 |
Well versus moderately + poorly |
|
|
|
Lymph node metastasis |
0.006 |
1.841 |
1.196-2.835 |
N0 + N1 versus N2 + N3 |
|
|
|
Depth of tumor invasion |
0.1 |
1.756 |
0.897-3.435 |
T1 + T2 versus T3 + T4 |
|
|
|
Liver metastasis |
0 |
3.461 |
2.002-5.983 |
Negative versus Positive |
|
|
|
Vascular invasion |
0.107 |
1.452 |
0.922-2.285 |
Negative versus Positive |
|
|
|
S100A9-positive inflammatory cell count |
0.046 |
0.643 |
0.417-0.991 |
<200 versus > = 200 |
RR: relative risk; CI: confidence interval.